EDITORIAL ON MANAGEMENT OF DRUG TOXICITYWOOLLEY PV.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 11; PP. 1091; BIBL. 7 REF.Article

HEPATIC AND PANCREATIC DAMAGE PRODUCED BY CYTOTOXIC DRUGS = LESIONS HEPATIQUES ET PANCREATIQUES SECONDAIRES A LA CHIMIOTHERAPIEWOOLLEY PV III.1983; CANCER TREATMENT REVIEWS; ISSN 0305-7372; GBR; DA. 1983; VOL. 10; NO 2; PP. 117-137; BIBL. 131 REF.; GRAPHArticle

CLINICAL STUDIES. IV. CLINICAL PHARMACOLOGY AND PHASE I TRIAL DESIGNWOOLLEY PV; SCHEIN PS.1979; METHODS CANCER RES.; USA; DA. 1979; VOL. 17; PP. 177-198; BIBL. 2 P.Article

A DEVELOPMENTAL ASSESSMENT CHART FOR NON-INSTITUTIONALIZED DOWN SYNDROME CHILDRENCHEN H; WOOLLEY PV JR.1978; GROWTH; USA; DA. 1978; VOL. 42; NO 2; PP. 157-165; BIBL. 31 REF.Article

POSSIBILITIES FOR A ROLE OF L-GLUTAMINE AND L-ASPARAGINE ANTAGONISTS IN THE TREATMENT OF GASTROINTESTINAL CANCERWOOLLEY PV III; COIT R; MAGNO M et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 6; PP. 1039-1040; BIBL. 4 REF.Article

BILIRUBIN AND BILIVERDIN TO RAT Y PROTEIN (LIGANDIN).WOOLLEY PV III; HUNTER MJ; ARIAS IM et al.1976; BIOCHIM. BIOPHYS. ACTA; PAYS-BAS; DA. 1976; VOL. 446; NO 1; PP. 115-123; BIBL. 17 REF.Article

DOUBLE ANEUPLOIDY: PARTIAL TRISOMY 21 AND XO/XXX IN A FAMILY WITH 12/21 TRANSLOCATIONCHEN H; TYRKUS M; WOOLLEY PV et al.1978; ANN. GENET.; FRA; DA. 1978; VOL. 21; NO 3; PP. 177-180; ABS. FRE; BIBL. 17 REF.Article

CLINICAL STRATEGIES IN THE CHEMOTHERAPY OF GASTROINTESTINAL CANCERMACDONALD JS; WOOLLEY PV; SCHEIN PS et al.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 179-185; BIBL. 13 REF.Conference Paper

DELAYED RADIATION NECROSIS OF BRAINSTEM RELATED TO FAST NEUTRON BEAM IRRADIATION. CASE REPORT AND LITERATURE REVIEWMANZ HJ; WOOLLEY PV; ORNITZ RD et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 2; PP. 473-479; BIBL. 42 REF.Article

PHASE II STUDY OF PCNU IN COLORECTAL CARCINOMAWILLIS LL; SCHEIN PS; WOOLLEY PV et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 11-12; PP. 1129-1130; BIBL. 5 REF.Article

PHASE II STUDY OF 5-FU, DOXORUBICIN, AND MITOMYCIN (FAM) AND CHLOROZOTOCIN IN ADVANCED MEASURABLE PANCREATIC CANCER = ESSAI PHASE II DE L'ASSOCIATION 5 FU, ADRIAMYCINE, MITOMYCINE (FAM) ET CHLOROZOTOCINE DANS LES CANCERS DU PANCREAS, AVANCES ET MESURABLESSMITH FP; RUSTGI VK; SCHERTZ G et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 12; PP. 2095-2096; BIBL. 5 REF.Article

TRIAL OF AMSA IN ACUTE LEUKEMIADUPONT JC; GARAY GE; SCAGLIONE C et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 7; PP. 1596-1597; BIBL. 6 REF.Article

MODIFICATION OF L1210 CELL NUCLEAR PROTEINS BY 1-METHYL-1-NITROSOUREA AND 1-METHYL-3-NITRO-1-NITROSOGUANIDINEPINSKY SD; TEW KD; SMULSON ME et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 3; PP. 923-928; BIBL. 30 REF.Article

NITROSOUREA INTERACTION WITH CHROMATIN AND EFFECT ON POLY(ADENOSINE DIPHOSPHATE RIBOSE) POLYMERASE ACTIVITYSUDHAKAR S; TEW KD; SCHEIN PS et al.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 4; PP. 1411-1417; BIBL. 38 REF.Article

PHARMACOLOGIC DISPOSITION OF CHLOROZOTOCIN IN MICEMHATRE RM; PANASCI LC; FOX P et al.1978; CANCER TREATM. REP.; USA; DA. 1978; VOL. 62; NO 8; PP. 1145-1151; BIBL. 11 REF.Article

FAST NEUTRON IRRADIATION FOR LOCALLY ADVANCED PANCREATIC CANCERSMITH FP; SCHEIN PS; MACDONALD JS et al.1981; INT. J. RADIAT. ONCOL., BIOL., PHYS.; ISSN 0360-3016; USA; DA. 1981; VOL. 7; NO 11; PP. 1527-1531; BIBL. 19 REF.Article

EXTRANODAL PRESENTATION OF NON-HODGKIN'S LYMPHOMAS IN THE TESTS.WOOLLEY PV III; OSBORNE CK; LEVI JA et al.1976; CANCER; U.S.A.; DA. 1976; VOL. 38; NO 2; PP. 1026-1035; BIBL. 35 REF.Article

THE EFFECT OF SEQUENTIAL ADDITION OF THE NITROSOUREA, CHLOROZOTOCIN, TO THE FAM COMBINATION IN ADVANCED GASTRIC CANCER = EFFET DE L'ADDITION SEQUENTIELLE DE CHLOROZOTOCINE, UNE NITROSOUREE, AU PROTOCOLE FAM DANS LES CANCERS AVANCES DE L'ESTOMACGISSELBRECHT C; SMITH FP; MACDONALD JS et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 10; PP. 1792-1794; ABS. ENG; BIBL. 9 REF.; GRAPHArticle

PHARMACOKINETICS AND PROTEIN BINDING OF CIS-DICHLORODIAMMINE PLATINUM(II) ADMINISTERED AS A ONE HOUR OR AS A TWENTY HOUR INFUSIONGULLO JJ; LITTERST CL; MAGUIRE PJ et al.1980; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1980; VOL. 5; NO 1; PP. 21-26; BIBL. 21 REF.Article

PHASE I CLINICAL TRIAL OF SPIROGERMANIUMSCHEIN PS; SLAVIK M; SMYTHE T et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 10-11; PP. 1051-1056; BIBL. 6 REF.Article

A PHASE II TRIAL OF FTORAFUR: ADRIAMYCIN AND MITOMYCIN-C (FAM II) IN ADVANCED GASTRIC ADENOCARCINOMAWOOLLEY PV III; MACDONALD JS; SMYTHE T et al.1979; CANCER; USA; DA. 1979; VOL. 44; NO 4; PP. 1211-1214; BIBL. 15 REF.Article

PHASE II TRIAL OF METHYL-G (METHYLGLYOXAL BIS-GUANYLHYDRAZONE) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMAFUKS IZ; VAN ECHO DA; AISNER J et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 411-414; BIBL. 14 REF.Article

CAMP (CYCLOPHOSPHAMIDE, DOXORUBICIN, METHOTREXATE, AND PROCARBAZINE) FOR EPIDERMOID AND LARGE CELL ANAPLASTIC CARCINOMA OF THE LUNGCAMBARERI RJ; SMITH FP; MACDONALD JS et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 3-4; PP. 317-320; BIBL. 15 REF.Article

5-FLUOROURACIL, ADRIAMYCIN, AND MITOMYCIN-C (FAM) CHEMOTHERAPY FOR ADVANCED ADENOCARCINOMA OF THE PANCREASSMITH FP; HOTH DF; LEVIN B et al.1980; CANCER; ISSN 0008-543X; USA; DA. 1980; VOL. 46; NO 9; PP. 2014-2018; BIBL. 14 REF.Article

PHASE II TRIAL OF STREPTOZOTOCIN, MITOMYCIN-C AND 5-FLUOROURACIL (SMF) IN THE TREATMENT OF ADVANCED PANCREATIC CANCER.WIGGANS RG; WOOLLEY PV III; MACDONALD JS et al.1978; CANCER; U.S.A.; DA. 1978; VOL. 41; NO 2; PP. 387-391; BIBL. 18 REF.Article